MTHFR C677T polymorphism is associated with methotrexate-induced myelopathy risk-Reference-Cited by-同舟云学术

MTHFR C677T polymorphism is associated with methotrexate-induced myelopathy risk

Published:2017-01-06 Issue:6 Volume:88 Page:603-604
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Juster-Switlyk Kelsey,Smith A. Gordon,Kovacsovics Tibor,Stephens Deborah,Glenn Martha,Palmer Cheryl Ann,Quigley Edward P.,Kolb Noah

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Reference7 articles.

1. Potential outcome factors in subacute combined degeneration

2. Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism

3. Phillips PC . Methotrexate neurotoxicity. In: Rottenberg DA , ed. Neurological Complications of Cancer Treatment, 1st ed. Stoneham: Butterworth-Heinemann; 1991:115–130.

4. Myelopathy following intrathecal chemotherapy in adults: a single institution experience;Cachia;J Neurooncol,2015

5. Methotrexate myelopathy with extensive transverse necrosis: report of an autopsy case;Shintaku;Neuropathology,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of MTHFR Polymorphisms With Leukoencephalopathy Risk in Patients With Primary CNS Lymphoma Treated With Methotrexate-Based Regimens;Neurology;2023-10-24

2. Intrathecal methotrexate induced myelopathy, rare yet serious complication: A case report and review of the literature;Current Research in Translational Medicine;2021-07

3. Myelopathies from Neoplasms;Seminars in Neurology;2021-05-24

4. Metabolic and Toxic Myelopathies;CONTINUUM: Lifelong Learning in Neurology;2021-02

5. Intrathecal cytosine arabinoside-induced progression of chronic methotrexate myelopathy;Neurological Sciences;2020-08-11